Mariner, LLC Kronos Bio, Inc. Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.73 - $1.38 $702,428 - $1.33 Million	962,231 Added 1221.11%	1,041,031 $1.29 Million
Q1 2024 May 15, 2024	BUY	$1.02 - $1.3 $80,376 - $102,440	78,800 New	78,800 $102,000
Q3 2023 Nov 13, 2023	BUY	$1.23 - $2.25 $2,589 - $4,736	2,105 Added 0.23%	917,436 $1.19 Million
Q2 2023 Aug 11, 2023	BUY	$1.24 - $1.92 $1.14 Million - $1.76 Million	915,331 New	915,331 $1.57 Million
Q4 2022 Feb 14, 2023	BUY	$1.44 - $3.44 $15,101 - $36,075	10,487 New	10,487 $17,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.